Literature DB >> 11420042

TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu.

W Chen1, M E Frank, W Jin, S M Wahl.   

Abstract

T cell apoptosis is critical to development and homeostasis of the immune system. The most salient feature of apoptosis is the lack of an attendant inflammatory response or tissue damage. Here, we present evidence that apoptotic T cells release TGF-beta, thereby contributing to an immunosuppressive milieu. Apoptotic T cells released not only latent but also bio-active TGF-beta. Nonetheless, TGF-beta transcription was not upregulated, suggesting release of existing rather than synthesis of new TGF-beta. Localized within the intracellular membrane-bound compartment, which includes mitochondria, TGF-beta was redistributed into the cytosol following loss of mitochondrial membrane potential. TGF-beta secreted from apoptotic T cells inhibited proinflammatory cytokine production by activated macrophages to foster immune suppression. These findings broaden the potential mechanisms whereby induction of immune tolerance or deficiency occurs through T cell deletion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420042     DOI: 10.1016/s1074-7613(01)00147-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  132 in total

1.  The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.

Authors:  Paul A Cardenas; Yiming Huang; Suzanne T Ildstad
Journal:  Chimerism       Date:  2011-07-01

2.  Distinctive role of efferocytosis in dendritic cell maturation and migration in sterile or infectious conditions.

Authors:  Letícia de Aquino Penteado; Naiara Naiana Dejani; Felipe Fortino Verdan; Allan Botinhon Orlando; Victoria Eugenia Niño; Fernanda De Nuzzi Dias; Ana Carolina Guerta Salina; Alexandra Ivo Medeiros
Journal:  Immunology       Date:  2017-04-10       Impact factor: 7.397

3.  Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Authors:  Lara Myers; Chikara Takahashi; Robert S Mittler; Robert J Rossi; Anthony T Vella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

Review 4.  The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?

Authors:  Christopher D Gregory; Andrew Devitt
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

5.  Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD.

Authors:  Shoba Amarnath; Francis A Flomerfelt; Carliann M Costanzo; Jason E Foley; Jacopo Mariotti; Daniel M Konecki; Anu Gangopadhyay; Michael Eckhaus; Susan Wong; Bruce L Levine; Carl H June; Daniel H Fowler
Journal:  Autophagy       Date:  2010-05-16       Impact factor: 16.016

6.  Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.

Authors:  Holly L Allen; George S Deepe
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

7.  Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.

Authors:  Amiram Ariel; Gabrielle Fredman; Yee-Ping Sun; Alpdogan Kantarci; Thomas E Van Dyke; Andrew D Luster; Charles N Serhan
Journal:  Nat Immunol       Date:  2006-10-01       Impact factor: 25.606

Review 8.  Signals from dying cells: tolerance induction by the dendritic cell.

Authors:  Thomas A Ferguson; Hirotaka Kazama
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis.

Authors:  Richard S Hotchkiss; Katherine C Chang; Mitchell H Grayson; Kevin W Tinsley; Benjamin S Dunne; Christopher G Davis; Dale F Osborne; Irene E Karl
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-07       Impact factor: 11.205

Review 10.  The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Authors:  Antonio Romo de Vivar Chavez; Michael E de Vera; Xiaoyan Liang; Michael T Lotze
Journal:  Med Oncol       Date:  2009-01-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.